ReviewInternational journal of clinical oncology2022

Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma.

Shu Shimada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.